{{htmlmetatags> metatag-keywords=(Vieillissement, Longévité, Qualité_de_vie, Revue_systématique) metatag-og:title=(Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer. Orillard E, et al, Cochrane Database Syst Rev 2024.) metatag-description=(Traduction du résumé de l'article : Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer. Orillard E, et al, The Cochrane database of systematic reviews 2024.) metatag-og:type=article metatag-article:published_time=2025-10-25 metatag-article:modified_time=2025-10-25 }} {{page>:priv:keywords&nofooter&noeditbtn}} ~~NOTOC~~ {{pmid>addtt:39136258|Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer.}} {{pmid>addhash_fr:39136258|Vieillissement, Longévité, Qualité_de_vie, Revue_systématique}} ====== Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer. Orillard E, et al, Cochrane Database Syst Rev 2024. ====== {{tag>Vieillissement, Longévité }} {{tag>Qualité_de_vie, Revue_systématique}} * **Proposé le :** 25/10/2025 04:07:11 * **Par :** [[:user:Bot]] * **Avec la version du site :** * **Revu par :** * //Mettre votre nom d'utilisateur// * //Mettre votre nom d'utilisateur// {{tag>Proposé_à_relecture 2025-10 Non_attribué Non_finalisé}} {{page>:veille:info:part_authors_instructions&noindent&nolink&nofooter&noeditbtn}} ===== Résumé et points clés ===== {{pmid>abstract_html:39136258}} ===== Références de l'article ===== {{pmid>listgroup:39136258}} ---- {{page>:veille:pm:discussion:39136258&nofooter&nolink&noindent}} [[:veille:pm:discussion:39136258?do=edit|Éditer la discussion]] ---- ===== Références ===== ~~REFNOTES~~ {{page>:start_news:start_newsletter&noident&nofooter&noeditbtn}}